Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Bioeutectics | 2025 | Convertible Note | Undisclosed | Mendoza |
| Bucha Bio | 2023 | Seed | Undisclosed | New York |
| Stämm | 2023 | Series B | Undisclosed | San Francisco |
| Surf Therapeutics | 2026 | Venture - Series Unknown | Undisclosed | Austin |
| Darma | 2022 | Venture - Series Unknown | $1.5M | Mountain View |
| Impact Biosystems | 2023 | Pre-Seed | $100K | Boston |
| Girihlet | 2022 | Debt Financing | $500K | Brooklyn |
| Kfobix Inc. | 2025 | Seed | $30K | Berkeley |
| DNALite Therapeutics | 2023 | Convertible Note | Undisclosed | San Francisco |
| LizarBio Therapeutics | 2022 | Seed | $525K | Dover |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Bioeutectics | Convertible Note | Undisclosed | Mendoza, Argentina |
| 127 | Bucha Bio | Seed | Undisclosed | New York, United States |
| 128 | Stämm | Series B | Undisclosed | San Francisco, United States |
| 129 | Surf Therapeutics | Venture - Series Unknown | Undisclosed | Austin, United States |
| 130 | Darma | Venture - Series Unknown | $1.5M | Mountain View, United States |
| 131 | Impact Biosystems | Pre-Seed | $100K | Boston, United States |
| 132 | Girihlet | Debt Financing | $500K | Brooklyn, United States |
| 133 | Kfobix Inc. | Seed | $30K | Berkeley, United States |
| 134 | DNALite Therapeutics | Convertible Note | Undisclosed | San Francisco, United States |
| 135 | LizarBio Therapeutics | Seed | $525K | Dover, United States |
Bioeutectics is revolutionising the solvent industry, turning it into one that is natural and biodegradable.
Novel biomaterials grown from infinitely renewable bacterial-nanocellulose.
Stämm is transforming biomanufacturing with nature-inspired, scalable, and sustainable solutions.
Surf Therapeutics is a clinical-stage firm leading the development of non-invasive ultrasound neuromodulation technology.
Darma is a global technology leader in fiber optic biosensors, dedicated to healthcare management service for chronic disease patients.
Impact Biosystems develops hardware and software solutions for people in the health and fitness space.
Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.
At Kfobix, our mission is to make green energy production facilities more sustainable with nanotechnology!
DNALite Therapeutics is an early-stage preclinical biotechnology company.
Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.
Bringing Ultrasound to the mass market with AI
Abbot's Butcher provides crafts premium plant-based meats.
Enabling tomorrow's therapies manufacturing for today's patients, with sound
Alora is an ocean agriculture company. We grow rice in the oceans.
TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.
Flair makes smart vents and wireless thermostats and advanced software for residential heating and cooling.
BioLattice addresses the need for tissue healing solutions.
Pulse Industrial is developing thermal applications using phase change materials.
Pioneering alternative fat solutions.
Advancing Clinical Research by Combining Machine Precision and Human Intuition
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.
InnSight Technology company is a biotechnology company intended to advance diagnostics and evaluation of eye disease.
Cocoon provides environmental consulting services to businesses and develops solutions to analyze and eradicate industrial waste.
SOSV has invested in 792 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
SOSV's top investment sectors include Biotechnology, Health Care, Life Science, Medical, Sustainability. The firm invests across 49 different industry categories.
Among tracked funding rounds, Mendel.ai received $40.0M in a Series B round. SOSV's total known invested capital is $3.6B.
SOSV's average investment size is $5.5M across its portfolio of 792 companies.
Recent SOSV portfolio additions include Bioeutectics, Bucha Bio, Stämm, Surf Therapeutics, Darma. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors